Coimbatore Sundararajan Venkatakrishnan, also known as Venkat within the bank, claims he would be “fully engaged” in business operations during his treatment, which is anticipated to last up to 16 weeks.
According to the bank, the CEO of Barclays has been diagnosed with cancer.
Venkat, also known as Coimbatore Sundararajan Venkatakrishnan, will receive treatment for non-Hodgkin lymphoma in New York.
This was anticipated to last between 12 and 16 weeks, during which he will occasionally work from home.
In a letter, Mr. Venkatakrishnan, 56, stated that his disease is treatable and that his prognosis is “good.”
“During this time, the company will operate normally, and I will remain actively involved in its management,” he wrote.
The good news is that the issue has been found early, and scans and biopsies have confirmed that it is well localized.
A representative for the bank acknowledged that no interim chief executive had been selected.
They noted that Venkat, an American citizen, may have to limit his public appearances, such as his anticipated January 2019 appearance at the World Economic Forum meetings in Davos.
Non-Hodgkin lymphoma is cancer that originates in the lymphatic system and weakens the immune system, but according to the NHS website, most instances are “quite curable.”
Mr. Venkatakrishnan was appointed to the position just over a year ago, following Jes Staley’s unexpected departure.
He was previously the bank’s chief of worldwide markets.
